News
Teva Pharmaceutical Industries Limited (TEVA)’s share was trading at $13.94 as of April 7th. TEVA’s trailing and forward P/E were 872 and 5.37 respectively according to Yahoo Finance. After ...
Teva (TEVA) Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries, announced the presentation of a patient and healthcare professional (HCP) attitudes and experiences survey study ...
Teva Pharmaceutical (NYSE:TEVA) and South Korean generic drugmaker Samsung Bioepis announced Monday the U.S. commercial availability of Epysqli, a biosimilar drug targeting AstraZeneca’s (NASDAQ ...
Teva and Samsung Bioepis are offering Epysqli, which is is a biosimilar to Alexion Pharmaceuticals' Soliris (eculizumab) for the treatment of paroxysmal nocturnal hemoglobinuria, atypical ...
Scattered Valley and Foothills rain and Sierra snow continue Saturday and Sunday. Snow will be fairly constant above 5,000' with weekend totals of up to 10" possible around Donner Summit and up to ...
Soliris® (eculizumab), making it one of the greatest cost-saving biosimilars to Soliris® in the U.S. Teva and Samsung Bioepis entered into a strategic partnership in January 2025 for the ...
GETTING SOME RAIN TODAY AND THAT WILL CONTINUE TOMORROW. SO GET READY. IN THE SIERRA SNOW MAKING IT FOR SOME SLICK TRAVEL AT TIMES. IT WAS HECTIC ON PORTIONS OF I-80 TODAY. WE’LL TALK ABOUT THAT ...
Norwich argued that if upheld, FDA’s determination will prohibit Norwich from marketing those products until at least June 29, 2028, assuming Teva launches its rifaximin product in January 2028.
In April 2025, GMC Sierra EV deals include low-interest long-term financing on the 2025 GMC Sierra EV Denali. Big Red also offers a $3,000 purchase allowance along with special and local market ...
The management of Israeli pharma group Teva has laid out its strategy for a return to growth after a challenging few years, with a greater emphasis on innovative medicines and a focus on complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results